Holen Sie sich die Stockscreener-App
0.4037
5.68%
0.0217
Handel nachbörslich:
.40
-0.0037
-0.92%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Prophase Labs Inc Aktie (PRPH) Neueste Nachrichten
ProPhase Labs Announces Successful Study Demonstrating Performan - GuruFocus
ProPhase Labs (PRPH) Advances with Positive Validation of BE-Smart Test | PRPH Stock News - GuruFocus
Prophase Labs Announces Successful Study Demonstrating Performance Of Be-Smart(TM) Test In Detecting Esophageal Cancer - MarketScreener
ProPhase Labs Inc. Validates BE-Smart™ Diagnostic Test for Esophageal Disease with Over 95% Success Rate - Nasdaq
ProPhase Labs Announces Successful Study Demonstrating - GlobeNewswire
Breakthrough: ProPhase's New Cancer Test Shows 95% Success Rate, Targets $10B Market - Stock Titan
ProPhase Labs Inc (PRPH)’s Market Momentum: Closing Strong at 0.33, Down -2.56 - DWinneX
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2025 Earnings Call Transcript - MSN
52,394 Shares in ProPhase Labs, Inc. (NASDAQ:PRPH) Acquired by Squarepoint Ops LLC - Defense World
ProPhase Labs Announces Formation of Clinical Science Advisory B - GuruFocus
ProPhase Labs (PRPH) Forms Advisory Board to Propel BE-Smart Tes - GuruFocus
ProPhase Labs (PRPH) Forms Advisory Board to Propel BE-Smart Test Commercialization | PRPH Stock News - GuruFocus
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform | PRPH Stock News - GuruFocus
ProPhase Labs Inc. Establishes Clinical Science Advisory Board to Advance BE-SmartTM Test for Esophageal Disease Detection - Nasdaq
ProPhase Labs forms advisory board for esophageal test - Investing.com
ProPhase Labs Announces Formation of Clinical Science - GlobeNewswire
ProPhase Labs Targets $14 Billion Market with Revolutionary Esophageal Cancer Detection Platform - Stock Titan
HBIXHarvest: Bitcoin Enhanced Income ETF - The Globe and Mail
ProPhase Labs’ Earnings Call: Strategic Moves Amid Challenges - TipRanks
ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance
ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strat - GuruFocus
ProPhase Labs Reports Q1 2025 Earnings and Strategic Developments - TipRanks
Transcript : ProPhase Labs, Inc., Q1 2025 Earnings Call, May 20, 2025 - marketscreener.com
ProPhase Labs, Inc. SEC 10-Q Report - TradingView
Earnings call transcript: ProPhase Labs beats Q1 2025 EPS forecast, stock rises - Investing.com
ProPhase Labs earnings beat by $0.05, revenue fell short of estimates - Investing.com Canada
Prophase Labs Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
ProPhase (PRPH) Awaits Potential $50 Million Insurance Recovery - GuruFocus
ProPhase (PRPH) Awaits Potential $50 Million Insurance Recovery | PRPH Stock News - GuruFocus
ProPhase (PRPH) Explores Strategic Sale of Nebula Genomics | PRPH Stock News - GuruFocus
ProPhase Labs (PRPH) Anticipates Extension for Nasdaq Listing | PRPH Stock News - GuruFocus
PRPH Streamlines Operations with Strategic Changes | PRPH Stock News - GuruFocus
ProPhase Labs Announces Financial Results for the Three Months E - GuruFocus
ProPhase Labs Inc Reports Q1 2025 EPS of $(0.13) and Revenue of $1.4 Million, Missing Estimates - GuruFocus
ProPhase Labs (PRPH) Focuses on Strategic Growth Amid Revenue De - GuruFocus
PROPHASE LABS Earnings Results: $PRPH Reports Quarterly Earnings - Nasdaq
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 | PRPH Stock News - GuruFocus
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 - GlobeNewswire
ProPhase Labs Slashes Costs by $8M, Reveals Three Major Value Drivers Including Potential $50M Collection - Stock Titan
ProPhase Labs Delays Form 10-Q Filing - TipRanks
ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025 - GlobeNewswire
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Bought by Renaissance Technologies LLC - Defense World
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript - MSN
Geode Capital Management LLC Boosts Stake in ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World
PRPHProphase Labs Inc Latest Stock News & Market Updates - Stock Titan
PRPH’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
There is no doubt that ProPhase Labs Inc (PRPH) ticks all the boxes. - Sete News
Metric Analysis: ProPhase Labs Inc (PRPH)’s Key Ratios in the Limelight - DWinneX
What was ProPhase Labs Inc (PRPH)’s performance in the last session? - uspostnews.com
Press Release Distribution & PR Platform - ACCESS Newswire
ProPhase Labs Inc (PRPH) is a good investment, but the stock may be overvalued - uspostnews.com
Daily Market Movement: ProPhase Labs Inc (PRPH) Sees a 0.54 Increase, Closing at 0.35 - DWinneX
Monitoring ProPhase Labs Inc (PRPH) after recent insider movements - knoxdaily.com
ProPhase Labs Inc (PRPH) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Investors Take Advantage Of 7.67% Gain In ProPhase Labs Inc (NASDAQ: PRPH) - Stocksregister
Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN
ProPhase Labs, Inc. (NASDAQ:PRPH) Short Interest Up 50.0% in March - Defense World
ProPhase Labs Closes $23.6M Asset Sale to Streamline Business Strategy - citybuzz -
ProPhase Labs Inc (NASDAQ: PRPH): Forecast Weak In 2025, Up -95.29% - Stocksregister
MicroStrategy Sees Insider Buy-Sell Action in Q1 - The Globe and Mail
1.52%
0.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):